FDA Expected To Move Up Vaccine Approval To Tonight

Welcome

LONDON, ENGLAND - DECEMBER 08: Sodium chloride is measured to be added to a phial of the Pfizer/BioNTech COVID-19 vaccine concentrate ready for administration at Guy's Hospital at the start of the largest ever immunisation programme in the UK's history on December 8, 2020 in London, United Kingdom. More than 50 hospitals across England were designated as covid-19 vaccine hubs, the first stage of what will be a lengthy vaccination campaign. NHS staff, over-80s, and care home residents will be among the first to receive the Pfizer/BioNTech vaccine, which recently received emergency approval from the country's health authorities. (Photo by Victoria Jones - Pool / Getty Images)

It was believed that the FDA would give emergency use authorization to Pfizer’s coronavirus vaccine over the weekend, but now the New York Times reports that the agency “is accelerating the timeline… aiming to issue it by Friday evening.”

People familiar with the F.D.A.’s planning say that regulators are now racing to complete the required paperwork that goes with the authorization, including a fact sheet and information for physicians. The timing of the announcement appears unlikely to speed up the shipment of the initial doses of the vaccine, the people said, raising questions about the purpose of expediting the authorization.

The first vaccines are expected to be administered as early as Monday.